Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06807918 · ClinicalTrials.gov registry record · Phase 2
Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder
A Phase 2 study, sponsored by University of Pennsylvania.
- Not yet
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT06807918: Clinical Trial Phase 2 study, sponsored by University of Pennsylvania.
NCT06807918 is a Phase 2 study that has not yet begun recruiting, run by University of Pennsylvania. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06807918, a Phase 2 study, has not yet begun recruiting, sponsored by University of Pennsylvania.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, crossover trial to evaluate the immediate effects of a nutritional ketone supplement, Kenotic compared to placebo on brain function and alcohol consumption in individuals with alcohol use disorder. Participants will complete 2 MRI scans, 2 FDG PET/CT scans, and 2 alcohol bar labs and will randomly receive Kenetik at one lab and the placebo at the next lab. During the bar labs participants will consume a dose of alcohol (based on weight), to bring their breath alcohol concentration to about 0.050%.
Interventions
- DIETARY_SUPPLEMENT Kenetik
- OTHER Placebo beverage
- OTHER magnetic resonance imaging scan
- OTHER fludeoxyglucose-18 positron emission tomography scan
- OTHER Alcohol bar lab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2030-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06807918
The ClinicalTrials.gov registry entry for NCT06807918 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Kenetik is the first listed.
NCT06807918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06807918 about?
NCT06807918 is a clinical study titled "Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder". This is a randomized, double-blind, crossover trial to evaluate the immediate effects of a nutritional ketone supplement, Kenotic compared to placebo on brain function and alcohol consumption in individuals with alcohol use disorder. Participants will complete 2 MRI scans, 2 FDG PET/CT scans, and 2 ...
What is the current status of trial NCT06807918?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2026-08-01. Estimated completion is 2030-01-01.
What interventions are being tested in trial NCT06807918?
The interventions under investigation include: Kenetik (DIETARY_SUPPLEMENT), Placebo beverage (OTHER), magnetic resonance imaging scan (OTHER), fludeoxyglucose-18 positron emission tomography scan (OTHER), Alcohol bar lab (OTHER).
Who is sponsoring clinical trial NCT06807918?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.